Aspirin Management for Bronchoscopy
Aspirin does not need to be held before bronchoscopy, including for procedures with transbronchial biopsy, as it does not increase bleeding risk.
Key Recommendation
The available guideline evidence from the British Thoracic Society addresses anticoagulants (warfarin, heparin) but does not specifically recommend holding aspirin before bronchoscopy 1. The BTS guidelines focus on stopping oral anticoagulants at least 3 days before bronchoscopy when biopsy is anticipated, but aspirin is not mentioned in these recommendations 1.
Supporting Evidence for Aspirin Continuation
Research demonstrates aspirin is safe during bronchoscopy: A 2016 study of 108 patients undergoing multimodality therapeutic bronchoscopy (including argon plasma coagulation, tumor debulking, and stent placement) found no significant difference in estimated blood loss between aspirin users and non-users (median 5.0 ml in both groups, p=0.36) 2.
No increased complication rates: The same study showed no difference in overall complications between patients taking aspirin versus those not taking aspirin during therapeutic bronchoscopy 2.
Broader bronchoscopy literature supports safety: Growing evidence indicates aspirin does not increase bleeding during bronchoscopy procedures, including transbronchial biopsies and endobronchial ultrasound with transbronchial needle aspiration 3.
Practical Algorithm
For Routine Bronchoscopy (with or without biopsy):
- Continue aspirin through the procedure 3, 2
- Check platelet count and coagulation parameters only if the patient has known bleeding risk factors 1
For Transbronchial Biopsy Specifically:
- Continue aspirin 3, 2
- Do check platelet count, prothrombin time, and partial thromboplastin time before the procedure 1
- Obtain chest radiograph at least 1 hour post-procedure to exclude pneumothorax 1
Contrast with Other Antiplatelet Agents
While aspirin can be continued, clopidogrel should be held for 7 days before elective bronchoscopy despite some small studies suggesting safety for low-risk procedures 3. The American College of Chest Physicians recommends stopping aspirin ≤7 days before non-cardiac surgery only when ASA interruption is deemed necessary, but this applies to high-bleed-risk surgeries (intracranial, spinal) rather than bronchoscopy 4.
Common Pitfalls to Avoid
Do not confuse aspirin management with warfarin management: The BTS guidelines clearly state oral anticoagulants must be stopped at least 3 days before bronchoscopy when biopsy is anticipated 1, but this does not apply to aspirin.
Do not unnecessarily discontinue aspirin in cardiovascular patients: Aspirin provides important cardiovascular protection, and the evidence shows it can be safely continued during bronchoscopy without increasing bleeding complications 2.
Aspirin has minimal effect on coagulation: Recent data in healthy volunteers showed low-dose aspirin (81 mg daily for 7 days) produced no significant change in thrombin generation parameters, confirming its limited impact on the coagulation cascade 5.